Navigation Links
Igenica Appoints Mary Haak-Frendscho, Ph.D., as Chief Executive Officer
Date:9/18/2012

BURLINGAME, Calif., Sept. 18, 2012 /PRNewswire/ -- Igenica, Inc., a leading biopharmaceutical company focused on the discovery and development of first-in-class cancer antibody therapeutics, today announced the appointment of Mary Haak-Frendscho, Ph.D., to the role of Chief Executive Officer and member of the Board of Directors. Dr. Haak-Frendscho succeeds David Goeddel, Ph.D., who remains as Igenica's Chairman of the Board.

Dr. Haak-Frendscho brings more than twenty years of experience in building robust biotechnology organizations for the discovery and development of novel therapeutic antibodies. Dr. Haak-Frendscho joins Igenica from Takeda, where she served as founding President and Chief Scientific Officer of Takeda San Francisco, establishing and overseeing Takeda's Center of Excellence for antibody biologics. Prior to Takeda, Dr. Haak-Frendscho held positions of increasing responsibility at XOMA, Abgenix and Genentech, where she secured collaborative relationships with external corporate partners, led antibody programs, and played a key role in the development of omalizumab (Xolair®, Genentech/ Novartis).  An immunologist by training, Dr. Haak-Frendscho holds degrees from the University of Michigan,Washington University, Stony Brook University (S.U.N.Y.), and the University of Wisconsin.

"Dr. Haak-Frendscho brings an exceptional range of experience and skills spanning antibody drug discovery and development, operations, strategic alliances and executive management," said Dr. Goeddel. "Her team-oriented approach will serve Igenica well as it transitions into its next stage of growth."

"I am delighted to be joining Igenica at this pivotal time in the company's history," said Dr. Haak-Frendscho.  "With strong support from The Column Group, 5AM Ventures, Orbimed Advisors and Third Rock Ventures, Igenica is well-positioned to be a powerhouse in target and antibody discovery exemplified by an exciting lead program, established discovery platforms and superb management team and scientific staff."

About Igenica, Inc.
Igenica, Inc. is a biopharmaceutical company pioneering breakthrough antibody-based cancer medicines. The company has integrated innovative technology platforms to address the major challenges to developing effective treatments for multiple oncology indications, with sTAg, a new approach to discovering and prioritizing novel tumor antigens, and iTAb, a functional in vivo antibody screening approach. Collectively, the two technology platforms drive Igenica's drug discovery efforts and promise to identify novel and more effective cancer therapeutics.

Igenica's Board of Directors includes David Goeddel, Ph.D., Managing Partner, The Column Group; John Diekman, Ph.D., Managing Partner, 5AM Ventures; Mark A. Goldsmith, M.D., Ph.D., Venture Partner, Third Rock Ventures; Carl Gordon, Ph.D., CFA, General Partner, Orbimed Advisors; Robert Schreiber, Ph.D., Alumni Endowed Professor of Pathology and Immunology, Professor of Molecular Microbiology and Tumor Immunology Program Leader for the Siteman Comprehensive Cancer Center at Washington University School of Medicine.

Contact:

John K. Celebi, MBA
Chief Business Officer
Igenica, Inc.
(650) 231-4320


'/>"/>
SOURCE Igenica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Igenica Closes $33 Million in Series C Funding
2. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
3. Circassia Appoints Stewart Sharpe as Vice President Commercial Operations
4. Pharmalink Consulting Appoints Chief Operating Officer for the Americas
5. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
6. EvaluatePharma Appoints Alexander Karle as COO
7. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
8. Insmed Appoints Will Lewis as President and Chief Executive Officer
9. Circassia Appoints Dr Brett Haumann as Chief Medical Officer
10. Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
11. Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , January 18, 2017 According to a new report ... Application: Global Opportunity Analysis and Industry Forecast, 2014 - 2022," the global polyphenol ... $1,127 million by 2022, growing at a CAGR of 8.26% from 2016 to ... of revenue. Continue Reading ... ...
(Date:1/18/2017)... GREENWOOD VILLAGE, Colo. , Jan. 18, 2017 /PRNewswire/ ... an independent chain of pharmacies based in ... Safe Rx™ Locking Prescription Vials (LPVs) in selected Good Day ... abuse now have a cost-effective alternative for secure storage," ... Safe Rx.  "For less than the price of a ...
(Date:1/18/2017)... , Jan. 18, 2017   Seno Medical ... of diagnosing breast cancer through the development of an ... Steve Miller as SVP of Engineering. Mr. ... Realization at FUJIFILM SonoSite, with headquarters in ... majority of his 30-year career to the development of ...
Breaking Medicine Technology:
(Date:1/18/2017)... Mich. USA; SAN JOSE, Calif, USA; and SHANGHAI, China – ... ... (PRWEB) January 18, 2017 -- Global public health organization ... reduce arsenic V (pentavalent arsenic) to NSF/ANSI 53: Drinking Water ... drinking water treatment units. This certification verifies that MicroCeramics’ NanoNose ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
(Date:1/18/2017)... ... 2017 , ... PrideStaff, a national, franchised staffing organization ... Turner Pizarro, was recently featured on Fox Business Network's Worldwide Business with kathy ... leaders from across the globe, provides viewers an opportunity to find solutions to ...
(Date:1/18/2017)... ... January 18, 2017 , ... Park Agencies Insurance ... services to families and business owners in the greater Kansas City area, is ... developmental disabilities. , The Lakemary Center is a comprehensive educational resource center that ...
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is an esteemed dentist ... His modern dental practice has two convenient office locations in Alexandria and Arlington, Virginia. ... Dentist for the Alexandria area. This award confirms the fact that Dr. Qureshi’s ...
Breaking Medicine News(10 mins):